Blood-based diagnostics of traumatic brain injuries
- PMID: 21171922
- PMCID: PMC3063529
- DOI: 10.1586/erm.10.104
Blood-based diagnostics of traumatic brain injuries
Abstract
Traumatic brain injury is a major health and socioeconomic problem that affects all societies. However, traditional approaches to the classification of clinical severity are the subject of debate and are being supplemented with structural and functional neuroimaging, as the need for biomarkers that reflect elements of the pathogenetic process is widely recognized. Basic science research and developments in the field of proteomics have greatly advanced our knowledge of the mechanisms involved in damage and have led to the discovery and rapid detection of new biomarkers that were not available previously. However, translating this research for patients' benefits remains a challenge. In this article, we summarize new developments, current knowledge and controversies, focusing on the potential role of these biomarkers as diagnostic, prognostic and monitoring tools of brain-injured patients.
Figures






References
-
- Ghajar J. Traumatic brain injury. Lancet. 2000;356:923–929. - PubMed
-
- Cole TB. Global road safety crisis remedy sought, 1.2 million killed, 50 million injured annually. JAMA. 2004;291:2531–2532. - PubMed
-
- Traumatic brain injury, time to end the silence. Lancet Neurol. 2010;9:331. - PubMed
-
- Brown AF, Cullen L, Than M. Future developments in chest pain diagnosis and management. Med. Clin. North Am. 2010;94:375–400. - PubMed
-
- Stocchetti N, Pagan F, Calappi E, et al. Inaccurate early assessment of neurological severity in head injury. J. Neurotrauma. 2004;21:1131–1140. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources